JP2005526727A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526727A5
JP2005526727A5 JP2003569178A JP2003569178A JP2005526727A5 JP 2005526727 A5 JP2005526727 A5 JP 2005526727A5 JP 2003569178 A JP2003569178 A JP 2003569178A JP 2003569178 A JP2003569178 A JP 2003569178A JP 2005526727 A5 JP2005526727 A5 JP 2005526727A5
Authority
JP
Japan
Prior art keywords
liposome
lipid
acid
active substance
spacer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2003569178A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526727A (ja
Filing date
Publication date
Priority claimed from DE10207177A external-priority patent/DE10207177A1/de
Application filed filed Critical
Publication of JP2005526727A publication Critical patent/JP2005526727A/ja
Publication of JP2005526727A5 publication Critical patent/JP2005526727A5/ja
Abandoned legal-status Critical Current

Links

JP2003569178A 2002-02-19 2003-02-19 ｐＨ感受性カチオン脂質、それを含有するリポソーム及びナノカプセル Abandoned JP2005526727A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10207177A DE10207177A1 (de) 2002-02-19 2002-02-19 Fakultativ kationische Lipide
PCT/EP2003/001661 WO2003070220A1 (de) 2002-02-19 2003-02-19 Ph sensitiv kationische lipide, lipsomen und nanokapseln, die diese umfassen

Publications (2)

Publication Number Publication Date
JP2005526727A JP2005526727A (ja) 2005-09-08
JP2005526727A5 true JP2005526727A5 (https=) 2006-04-06

Family

ID=27674784

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003569178A Abandoned JP2005526727A (ja) 2002-02-19 2003-02-19 ｐＨ感受性カチオン脂質、それを含有するリポソーム及びナノカプセル

Country Status (6)

Country Link
US (1) US8192753B2 (https=)
EP (1) EP1480621A1 (https=)
JP (1) JP2005526727A (https=)
AU (1) AU2003210303A1 (https=)
DE (1) DE10207177A1 (https=)
WO (1) WO2003070220A1 (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003093449A2 (en) * 2002-05-06 2003-11-13 Nucleonics, Inc. Methods for delivery of nucleic acids
EP1706149A2 (en) * 2004-01-15 2006-10-04 Alza Corporation Liposome composition for delivery of therapeutic agents
KR20080082956A (ko) 2005-09-15 2008-09-12 노보솜 아게 양쪽성 리포솜의 개선 또는 양쪽성 리포솜에 관련된 개선
US20080088046A1 (en) * 2006-10-13 2008-04-17 Steffen Panzner Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome
US8101741B2 (en) 2005-11-02 2012-01-24 Protiva Biotherapeutics, Inc. Modified siRNA molecules and uses thereof
CA2631677C (en) * 2005-12-01 2014-08-12 Pronai Therapeutics, Inc. Amphoteric liposome formulation
RU2451022C2 (ru) * 2005-12-15 2012-05-20 Сантр Насьональ Де Ля Решерш Сьентифик (Снрс) Катионные олигонуклеотиды, автоматизированные способы их получения и их применение
EP1844772A1 (en) * 2006-04-06 2007-10-17 Polyplus-Transfection SA Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
JP5424885B2 (ja) 2006-10-13 2014-02-26 マリーナ バイオテック，インコーポレイテッド 両性リポソームにおけるまたは両性リポソームに関する改善、両性リポソームを処方する方法および両性リポソームに充填する方法
WO2008074487A2 (en) * 2006-12-19 2008-06-26 Novosom Ag Lipids and lipid assemblies comprising transfection enhancer elements
WO2009082817A1 (en) 2007-12-27 2009-07-09 Protiva Biotherapeutics, Inc. Silencing of polo-like kinase expression using interfering rna
FR2926818B1 (fr) * 2008-01-30 2012-04-06 Centre Nat Rech Scient siRNA CATIONIQUES, SYNTHESE ET UTILISATION POUR L'ARN INTERFERENCE
JP2011516094A (ja) 2008-04-15 2011-05-26 プロチバ バイオセラピューティクス インコーポレイティッド 干渉ｒｎａを用いたｃｓｎ５遺伝子発現のサイレンシング方法
JP5588619B2 (ja) * 2009-03-11 2014-09-10 一丸ファルコス株式会社 ｐＨ応答性リポソーム
CA2784568A1 (en) 2009-12-18 2011-06-23 The University Of British Columbia Lipid particles for delivery of nucleic acids
EP2582387A2 (en) 2010-06-17 2013-04-24 The United States Of America As Represented By The Secretary, National Institutes Of Health Compositions and methods for treating inflammatory conditions
PL2591114T3 (pl) 2010-07-06 2017-08-31 Glaxosmithkline Biologicals Sa Immunizacja dużych ssaków małymi dawkami rna
HUE047796T2 (hu) 2010-07-06 2020-05-28 Glaxosmithkline Biologicals Sa RNS bevitele több immunútvonal bekapcsolására
RS63817B1 (sr) 2010-07-06 2023-01-31 Glaxosmithkline Biologicals Sa Čestice za isporuku slične virionu za molekule samoreplicirajuće rnk
HUE026646T2 (en) 2010-07-06 2016-07-28 Glaxosmithkline Biologicals Sa Preferred liposomes containing lipids of PKA value for delivery of RNA
PT3970742T (pt) 2010-08-31 2022-06-27 Glaxosmithkline Biologicals Sa Lipossomas peguilados para entrega de arn codificador de imunogénio
JP2013544504A (ja) 2010-10-11 2013-12-19 ノバルティス アーゲー 抗原送達プラットフォーム
US10849975B2 (en) 2011-02-03 2020-12-01 Thomas Jefferson University Multivalent vaccines for rabies virus and filoviruses
WO2012109495A1 (en) 2011-02-09 2012-08-16 Metabolic Solutions Development Company, Llc Cellular targets of thiazolidinediones
US8789967B2 (en) 2011-06-02 2014-07-29 Musco Corporation Apparatus, method, and system for independent aiming and cutoff steps in illuminating a target area
WO2013006838A1 (en) 2011-07-06 2013-01-10 Novartis Ag Immunogenic combination compositions and uses thereof
WO2013032643A2 (en) * 2011-08-31 2013-03-07 Dicerna Pharmaceuticals, Inc. Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells
AU2012340086A1 (en) 2011-11-17 2014-05-29 The Regents Of The University Of California Therapeutic RNA switches compositions and methods of use
US9035039B2 (en) 2011-12-22 2015-05-19 Protiva Biotherapeutics, Inc. Compositions and methods for silencing SMAD4
CN104884065B (zh) 2012-09-21 2019-01-01 强烈治疗剂公司 治疗癌症的方法
BR112015010220A2 (pt) 2012-11-05 2017-12-05 Pronai Therapeutics Inc métodos de utilização de biomarcadores para tratamento de câncer
JP6339884B2 (ja) 2014-07-17 2018-06-06 富士フイルム株式会社 イミダゾール化合物およびそれを含有するリポソーム
BR112017006679A2 (pt) 2014-10-02 2017-12-26 Protiva Biotherapeutics Inc moléculas, composição, partícula, composição farmacêutica, métodos para silenciar a expressão de um gene, usos de uma partícula, métodos para melhorar um ou mais sintomas, métodos para tratar uma infecção, usos de uma composição, método para inibir a replicação do vírus da hepatite d
US20180245074A1 (en) 2015-06-04 2018-08-30 Protiva Biotherapeutics, Inc. Treating hepatitis b virus infection using crispr
CN108350455A (zh) 2015-07-29 2018-07-31 阿布特斯生物制药公司 用于使b型肝炎病毒基因表达沉默的组合物和方法
WO2017040702A1 (en) * 2015-08-31 2017-03-09 The Regents Of The University Of California Bipolar tetraether lipids
MX2018010198A (es) 2016-02-25 2019-06-12 Applied Biological Laboratories Inc Composiciones y metodos para proteger contra patogenos e irritantes transportados por el aire.
US12447166B2 (en) 2016-02-25 2025-10-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
WO2017176596A1 (en) 2016-04-04 2017-10-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and coronaviruses
EP3500294A4 (en) 2016-08-22 2020-07-29 Arbutus Biopharma Corporation ANTI-PD-1 ANTIBODIES, OR THEIR FRAGMENTS, FOR THE TREATMENT OF HEPATITIS B
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device
KR20230011913A (ko) 2020-03-04 2023-01-25 버브 테라퓨틱스, 인크. 표적화된 rna 전달을 위한 조성물 및 방법
JP7848179B2 (ja) * 2021-03-09 2026-04-20 日本精化株式会社 リン脂質
JP2024530647A (ja) 2021-08-03 2024-08-23 ヴァーヴ・セラピューティクス，インコーポレーテッド 標的ｒｎａ送達のための組成物および方法
CN115894281B (zh) * 2021-09-22 2025-07-01 广州谷森制药有限公司 阳离子脂质化合物、其制备方法、组合物及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE45744T1 (de) * 1984-07-25 1989-09-15 Ciba Geigy Ag Phosphatidylverbindungen, verfahren zu ihrer herstellung und ihre verwendung.
CA2032259A1 (en) * 1989-12-18 1991-06-19 Wayne J. Thompson Hiv protease inhibitors useful for the treatment of aids
JP2604268B2 (ja) * 1990-04-09 1997-04-30 富士写真フイルム株式会社 ペプチド誘導体両親媒性化合物、その中間体、ペプチド誘導体両親媒性化合物を用いたリポソームおよび薄膜
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5334761A (en) * 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
FR2701396B1 (fr) * 1993-02-12 1995-04-21 Oreal Procédé de stabilisation de vésicules de lipide(s) amphiphile(s) et composition pour application topique contenant lesdites vésicules stabilisées.
US6020317A (en) * 1993-02-19 2000-02-01 Nippon Shinyaku Co. Ltd. Glycerol derivative, device and pharmaceutical composition
US5354853A (en) * 1993-03-12 1994-10-11 Genzyme Corporation Phospholipid-saccharide conjugates
US5965434A (en) * 1994-12-29 1999-10-12 Wolff; Jon A. Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds
FR2756565B1 (fr) * 1996-12-04 1998-12-31 Oreal Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie
JPH11199488A (ja) * 1998-01-09 1999-07-27 Sankyo Co Ltd 抗腫瘍薬のリポソーム化製剤
JPH11217328A (ja) * 1998-01-28 1999-08-10 Nissin Food Prod Co Ltd 抗ｈｉｖ活性を発現する脂質集合体
US6656498B1 (en) 1998-11-25 2003-12-02 Vanderbilt University Cationic liposomes for gene transfer
US7112337B2 (en) * 1999-04-23 2006-09-26 Alza Corporation Liposome composition for delivery of nucleic acid
WO2001026625A2 (en) * 1999-10-08 2001-04-19 Alza Corp Neutral-cationic lipid for nucleic acid and drug delivery
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
DE10109897A1 (de) * 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser

Similar Documents

Publication Publication Date Title
JP2005526727A5 (https=)
US9387262B2 (en) Coated lipid complexes and their use
KR102299053B1 (ko) Rna 전달을 위한 이온화가능한 양이온성 지질
JP2005517739A5 (https=)
JP7708388B2 (ja) 荷電物質を送達する脂質、その製剤、およびその製造方法
HUT77171A (hu) Lipopoliaminok mint transzfekciós ágensek, és ezeket tartalmazó gyógyászati készítmények
KR20190021218A (ko) 양이온성 지질
CN111417621A (zh) 阳离子脂质
CN121698765A (zh) pH敏感性阳离子性脂质、脂质纳米粒子、含有脂质纳米粒子的医药用组合物以及脂质纳米粒子的用途
EP4709710A1 (en) Ionizable cationic lipids for rna delivery
CN119528753A (zh) 含氮链状化合物、制备方法、包含其的组合物和应用
Le Bolc'h et al. Cationic Phosphonolipids as non Viral Vectors
WO2018033883A2 (en) Ph-responsive lipids
JP2021178780A (ja) 末端修飾ポリアミドアミンデンドロン脂質
US7368129B1 (en) Amphiphilic materials and liposome formulations thereof
JP2008303210A (ja) 低級アシル基含有ポリアミドアミンデンドロン脂質
HK40076264A (en) Lipids for delivery of charged material, formulations thereof and method for making same
CN118027129A (zh) 一种可电离脂质化合物及其应用
CN121752256A (zh) 具有核酸负载物和可电离脂质的脂质纳米颗粒
JPWO1999043752A1 (ja) 負電荷物質を輸送するための組成物